Form 4: Veracyte Director Karin Eastham Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Karin Eastham reports acquiring and disposing of Veracyte, Inc. common stock on June 13, 2024, according to a Form 4 filing.
Summary
- Karin Eastham, a director of Veracyte, Inc., filed a Form 4 disclosing changes in beneficial ownership of the company's stock.
- On June 13, 2024, Eastham acquired 11,473 shares of common stock.
- On the same day, Eastham disposed of shares of common stock.
- Following these transactions, Eastham beneficially owns 40,728 shares of Veracyte common stock.
- The filing also mentions restricted stock units awarded on June 13, 2024, which vest on the first anniversary of the grant date or earlier under certain conditions.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company directors.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of stock acquisition and disposal, and grant date of restricted stock units. |
| 06/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.